Antibiotice (BSE:ATB) Debt-to-Asset : 0.06 (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Antibiotice Debt-to-Asset?

Antibiotice's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was lei29.6 Mil. Antibiotice's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was lei36.8 Mil. Antibiotice's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was lei1,139.2 Mil. Antibiotice's debt to asset for the quarter that ended in Dec. 2023 was 0.06.

Antibiotice Debt-to-Asset Historical Data

The historical data trend for Antibiotice's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antibiotice Debt-to-Asset Chart

Antibiotice Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.23

0.19

0.16

0.08

0.06

Antibiotice Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial															0.08	0.10	0.09	0.08	0.06

Competitive Comparison of Antibiotice's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Antibiotice's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Antibiotice's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Antibiotice's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Antibiotice's Debt-to-Asset falls into.

Antibiotice Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Antibiotice's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(29.552	+	36.75)	/	1139.172
	=	0.06

Antibiotice's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(29.552	+	36.75)	/	1139.172
	=	0.06

Antibiotice (BSE:ATB) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Antibiotice Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Antibiotice's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Antibiotice (BSE:ATB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Antibiotice SA (BSE:ATB) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Valea Lupului Street, Iasi, ROU, 707410

Website

http://www.antibiotice.ro

Antibiotice Ord is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).

Antibiotice (BSE:ATB) Headlines

No Headlines